- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ContraFect Corp (CFRXQ)
Track today's live ContraFect Corp (CFRXQ) share price, performance and key data on this page with our current OTC Markets:CFRXQ stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the ContraFect Corp share price on the OTC Markets exchange. Use the dropdown to switch exchange for the CFRXQ share price, head to our technical summary section, which provides analysis on ContraFect Corp share price buy/sell indicators using real-time data (or discuss the ContraFect Corp (CFRXQ) stock price today with other investors in the ContraFect Corp OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC:CFRXQ share price (ISIN: US2123264093) to enhance your trading decisions with our free investment tools and resources.
What Is the ContraFect Corp Share Price Today?
The ContraFect Corp share price today is 0.001.
What Is the Stock Symbol for ContraFect Corp
The stock symbol (or 'ticker') for ContraFect Corp is "CFRXQ."
What Stock Exchange Does ContraFect Corp Trade On?
ContraFect Corp is listed and trades on the OTC Markets stock exchange.
Is ContraFect Corp a Good Stock to Buy?
Determining whether ContraFect Corp (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current OTC:CFRXQ share price (ISIN: US2123264093) to enhance your trading decisions with our free investment tools and resources.
What Is the ContraFect Corp Share Price Today?
The ContraFect Corp share price today is 0.001.
What Is the Stock Symbol for ContraFect Corp
The stock symbol (or 'ticker') for ContraFect Corp is "CFRXQ."
What Stock Exchange Does ContraFect Corp Trade On?
ContraFect Corp is listed and trades on the OTC Markets stock exchange.
Is ContraFect Corp a Good Stock to Buy?
Determining whether ContraFect Corp (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
OTC Markets
Currency in USD
0.001
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.001
0.001
52 wk Range
0.001
0.001
Trading near 52-week High
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0010.001
52 wk Range
0.0010.001
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CFRXQ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Earnings
Latest Release
14/11/2023
EPS / Forecast
-0.50 / -0.66
Revenue / Forecast
-- / --
Compare CFRXQ to Peers and Sector
Metrics to compare | CFRXQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCFRXQPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.8x | −0.4x | |
PEG Ratio | 0.00 | −0.04 | 0.00 | |
Price/Book | 0.0x | 0.9x | 2.6x | |
Price / LTM Sales | 0.0x | 4.0x | 3.1x | |
Upside (Analyst Target) | 0.0% | 454.6% | 48.5% | |
Fair Value Upside | Unlock | −8.2% | 5.8% | Unlock |
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus. The company also developing CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also developing CF-296, an osteomyelitis and PJI which is in preclinical trailers for the treatment of joint infections. In addition, the company developing Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. Further, It develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. On December 4, 2023, ContraFect Corporation filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the ContraFect Corp (OTC Markets: CFRXQ) Share Price Today?
The ContraFect Corp stock price today is 0.001 USD.
What Stock Exchange Does ContraFect Corp (CFRXQ) Trade On?
ContraFect Corp is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for ContraFect Corp?
The stock symbol (also called a 'ticker') for ContraFect Corp is "CFRXQ."
What Is the Current ContraFect Corp Market Capitalisation?
As of today, ContraFect Corp (OTC Markets: CFRXQ) market cap is 10.700K USD.
Is CFRXQ a Buy or Sell From a Technical Analyst Perspective?
Based on today's ContraFect Corp moving averages and other technical indicators, the daily buy/sell signal for CFRXQ stock is Strong Sell.
How Many Times Has ContraFect Corp Stock Split?
ContraFect Corp has split 2 times. (See the CFRXQ stock split history page for full effective split date and price information.)
How Many Employees Does ContraFect Corp Have?
ContraFect Corp has 23 employees, based on their latest Companies House report.
What is the current trading status of ContraFect Corp (OTC Markets: CFRXQ)?
As of 10/08/2026, ContraFect Corp (CFRXQ) is trading at a share price of 0.001 USD, with a previous close of 0.000 USD. The stock has fluctuated within a day range of 0.001 USD to 0.001 USD, while its 52-week range spans from 0.001 USD to 0.001 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.